en

PRODUCT DETAIL

Topimark 25 mg

Code 50768
MA number 21/0185/08-S
Product Form: tbl flm 20x25 mg (fľ.HDPE)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 21 - ANTIEPILEPTICA, ANTICONVULSIVA
ATC:
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AX Other antiepileptics
N03AX11 Topiramate
Shelf life: 30
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 29.05.2008
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric contraindication: Yes
Pediatric warnings: Yes
Dokument: DHPC_Topiramát_obmedzenia na zabránenie expozicie topiramátu počas tehot....pdf  
Dokument: Topiramát_Príručka pre zdravotníckych pracovníkov.pdf  
Dokument: Topiramát_Príručka pre pacientku.pdf  
Dokument: Topiramát_Formulár informovanosti o rizikách.pdf  
PIL: PIL_Topimark 25 50 100 mg_04.2024.pdf  
SPC: SPC_Topimark_tbl flm_06.2024.pdf  
Safety feature Yes
Data update: 06.11.2018
eu-flag.png sk-flag.png